Hlscience KRX:239610KOSDAQ
에이치엘사이언스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked2since Sep 11
In Q2 2026, Hlscience reported revenue of ₩2.5bn, down 57.1% year on year, and an operating loss of ₩2.8bn. Hlscience (에이치엘사이언스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals 4 quarters of losses Screener
Hlscience quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩2.5bn | -57.1% | −₩2.8bn margin −111.6% | −₩2.5bn |
| Q1 2026 | ₩2.1bn | -58.0% | −₩2.2bn margin −105.2% | −₩1.9bn |
| Q4 2025 derived | ₩2.4bn | -37.2% | −₩2.4bn margin −101.6% | −₩4.6bn |
| Q3 2025 | ₩3.5bn | -1.2% | −₩2.6bn margin −76.0% | −₩2.2bn |
| Q2 2025 | ₩5.8bn | +10.0% | −₩3.1bn margin −52.9% | −₩2.6bn |
| Q1 2025 | ₩5.1bn | -1.0% | −₩3.0bn margin −58.2% | −₩2.5bn |
| Q4 2024 derived | ₩3.7bn | -35.2% | −₩3.8bn margin −102.4% | −₩4.0bn |
| Q3 2024 | ₩3.5bn | -40.3% | −₩1.7bn margin −47.4% | −₩1.0bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Hlscience top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.